2013
Pacific Edge Half Year Report 2013
Please click link to download Pacific Edge's Full Half Year Report for the six months ended 30 September 2013. [read more]
Videos from 2013 NZ Innovation Awards
Video Highlights from the 2013 NZ Innovation Awards where Pacific Edge won the Supreme Award. [read more]
Pacific Edge shareholder rights offer closes
Pacific Edge's 2 for 15 pro rata renounceable rights offer of new Pacific Edge shares ("New Shares") closed yesterday. [read more]
Pacific Edge signs Cxbladder agreement with third national provider network in the US
Pacific Edge has signed an agreement with Stratose, a large national provider network in the USA, to enable the provision of Cxbladder to patients through its large network of payers and providers. [read more]
Double Shot Interview with David Darling, CEO of Pacific Edge
Andrew Patterson talks to David Darling of Pacific Edge about making a key bio-tech partnership with the University of Otago pay off in a big way. [read more]
Cxbladder is Supreme Winner at NZ Innovators Awards
Pacific Edge is the 2013 Supreme Winner of the NZ Innovators Award for Cxbladder, its novel gene test for the detection and management of bladder cancer. [read more]
First Commercial Sales Achieved for Pacific Edge's Cxbladder in the USA
Cancer diagnostic specialist Pacific Edge (NZX:PEB) is delighted to announce that it has completed the first commercial sales of Cxbladder tests signalling the start of the commercial revenue for the company in the US. [read more]
Pacific Edge Agreement With National Provider Network FedMed Gives 40 Million Americans Access to Cxbladder
Pacific Edge (NZX:PEB), a cancer diagnostic company leading in the development and commercialisation of molecular diagnostic tests, has signed an agreement with FedMed, a national preferred provider network in the United States, to make Cxbladder available to an additional 40 million Americans. [read more]
US Accolade with Accreditation Granted to Pacific Edge NZ Laboratory
Cancer diagnostic specialist Pacific Edge has joined an elite group of organisations outside the United States with the registration of Pacific Edge Diagnostics Dunedin laboratory to conduct Cxbladder tests under the CLIA regulatory process. [read more]
Pacific Edge Named as Innovation Awards Finalists
We are proud to announce that Pacific Edge has been named as a finalist in the Health and Science category of the 2013 New Zealand Innovators Awards for our bladder cancer detection test, Cxbladder. [read more]
Cxbladder excels in New Zealand
New Zealand clinicians and healthcare providers are excited about Pacific Edge Limited's cancer detection system Cxbladder for its ability to detect bladder cancer with a high degree of accuracy. [read more]
Pacific Edge 2012-2013 AGM CEO Presentation
Please click the following link to download our CEO's 2012-2013 Shareholder Presentation [read more]
Pacific Edge Appoints Independent Director
Bryan Williams FRSNZ, FAA, who has a distinguished career in cancer research and international business, has accepted appointment to the Board of Pacific Edge Limited as an Independent Director. [read more]
Pacific Edge Annual Report 2013
Please click link to download Pacific Edge's 2013 Annual Report [read more]
Update on U.S. Commercialisation Pathway Presentation
Please click link to download Pacific Edge's PEB Investor Update Presentation [read more]
MidCentral DHB first in New Zealand to utilise Cxbladder
MidCentral District Health Board, based in Palmerston North, is set to become the first district health board in New Zealand to become a commercial customer for Pacific Edge's diagnostic cancer test Cxbladder. [read more]
Pacific Edge: Preliminary Full Year Disclosure
FY2013 Results Summary [read more]
National Accounts Manager Appointed for USA
Michael Maltby has joined Pacific Edge Diagnostics USA (PEDUSA) as the new Director of National Accounts and Payer Relations. [read more]
China Grants Patent for Detection of Gastric Cancer
China, with one of the highest incidences of stomach (Gastric) cancer in the world, has granted Pacific Edge Limited (the Company) its patent, Detection of Gastric Cancer patent defines technology that can be used by the Company for the diagnosis of gastric cancer. [read more]
Pacific Edge: Preliminary Full Year Disclosure
The 2012-13 financial year has been a landmark year for the Company with major milestones being achieved in the commercialisation of the Company's intellectual property portfolio. [read more]
Pacific Edge's US laboratory receives CLIA registration for Cxbladder
Cancer diagnostic specialist Pacific Edge has achieved a major milestone with notification that its commercial laboratory in Hershey, Pennsylvania, has gained registration under the CLIA[1] regulatory process clearing the way for the launch of Cxbladder in the United States. [read more]
Pacific Edge CLIA Certification Presentation
Please click link to download Pacific Edge's CLIA Certification Presentation [read more]
Pacific Edge Appoints Director to US Board Ahead of Anticipated Cxbladder Launch
Pacific Edge has taken a further significant step in the commercialisation in the United States of its ground breaking cancer diagnostic test, Cxbladder, with a high calibre appointment to its US subsidiary, Pacific Edge Diagnostics USA, PEDUSA Board of Directors. [read more]
Pacific Edge Diagnostics NZ Appoints NZ-Australia Commercial Manager
Pacific Edge Diagnostics NZ is pleased to announce the appointment of Brent Pownall as Commercial Manager. Brent Joins the team in Dunedin from Auckland and will lead the commercial activity of Pacific Edge's innovative and non-invasive bladder cancer diagnostic system Cxbladder in New Zealand and Australia. [read more]
NZTE video: David Darling discusses roll-out of Cxbladder in the US
David Darling, Pacific Edge Ltd CEO, discusses roll-out of the Cxbladder test into the United States market with New Zealand Trade and Enterprise (NZTE) at the US Health Immersion Program in Washington DC. [read more]
Pacific Edge signs agreement with America's Choice Provider Network to expand access to Cxbladder in the US
Pacific Edge has signed an agreement with America's Choice Provider Network (ACPN) to provide more Americans access to Cxbladder. [read more]
Congratulations to Dr Sanjeev Bandi on his incredible achievements in raising funds for Movember in 2012
The team at Pacific Edge would like to congratulate Dr Sanjeev Bandi on his Movember fundraising efforts this November. [read more]
Cxbladder mentioned in Sir Peter Leitch's Newsletter
Sir Peter Leitch has kindly mentioned Cxbladder in his Mad Butcher Club Newsletter (#50) [read more]
View our Calendar of Events
We welcome press and media enquiries. For further assistance, please feel free to contact us.